Gamma-aminobutyric acid (GABA) inhibitors, or GABA antagonists, are drugs that inhibit the action of GABA, the primary inhibitory neurotransmitter of the central nervous system. They predominantly work at the GABA receptor. GABA receptors categorize into the GABA-A receptor and GABA-B receptor subtypes.[1] A GABA-C receptor also exists, but it is typically classified as a subtype of GABA-A
Drugs that are used to regulate GABA signaling include: Benzodiazepines: Bind to the GABA-A receptor, resulting in a calming effect. Barbiturates: Sedative drugs that increase how long GABA binds to the GABA-A receptor. Vigabatrin: Used to prevent the breakdown of GABA, helping to treat certain types of epilepsy.
Gamma-aminobutyric acid (GABA) inhibitors, or GABA antagonists, are drugs that inhibit the action of GABA, the primary inhibitory neurotransmitter of the central nervous system. They predominantly work at the GABA receptor. GABA receptors categorize into the GABA-A receptor and GABA-B receptor subtypes.[1] A GABA-C receptor also exists, but it is typically classified as a subtype of GABA-A
Gamma-aminobutyric acid (GABA) inhibitors, or GABA antagonists, are drugs that inhibit the action of GABA, the primary inhibitory neurotransmitter of the central nervous system. They predominantly work at the GABA receptor. GABA receptors categorize into the GABA-A receptor and GABA-B receptor subtypes.[1] A GABA-C receptor also exists, but it is typically classified as a subtype of GABA-A
Gamma-aminobutyric acid (GABA) inhibitors, or GABA antagonists, are drugs that inhibit the action of GABA, the primary inhibitory neurotransmitter of the central nervous system. They predominantly work at the GABA receptor. GABA receptors categorize into the GABA-A receptor and GABA-B receptor subtypes.[1] A GABA-C receptor also exists, but it is typically classified as a subtype of GABA-A
vs. unexposed to antiepileptic drugs was 0.99 (0.80-1.23). Overall, there inhibitors, GABA uptake inhibitors, GABA agonists, and GABA prodrugs. In
Drugs that are used to regulate GABA signaling include: Benzodiazepines: Bind to the GABA-A receptor, resulting in a calming effect. Barbiturates: Sedative drugs that increase how long GABA binds to the GABA-A receptor. Vigabatrin: Used to prevent the breakdown of GABA, helping to treat certain types of epilepsy.
Gamma-aminobutyric acid (GABA) inhibitors, or GABA antagonists, are drugs that inhibit the action of GABA, the primary inhibitory neurotransmitter of the central nervous system. They predominantly work at the GABA receptor. GABA receptors categorize into the GABA-A receptor and GABA-B receptor subtypes.[1] A GABA-C receptor also exists, but it is typically classified as a subtype of GABA-A
Barbiturates: Sedative drugs that increase how long GABA binds to the GABA-A receptor; Vigabatrin: Used to prevent the breakdown of GABA
Comments